| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Former Director | EVP, R&D &Chief Scientific Of +1 more
3 companies
Haqq Christopher is an EVP, R&D &Chief Scientific Of at Atara Biotherapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $14.35 | $86,100.00 | -1.7% | |
| Sep 15, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $15.30 | $91,800.00 | -1.7% | |
| Aug 15, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sale+OE | 7,604 | $14.75 | $112,159.00 | -2.1% | |
| Jul 17, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $14.92 | $89,520.00 | -1.6% | |
| Jun 15, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $12.65 | $75,900.00 | -1.6% | |
| May 15, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sale+OE | 7,604 | $14.99 | $113,983.96 | -2.0% | |
| Apr 17, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $17.28 | $103,680.00 | -1.6% | |
| Mar 15, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $19.60 | $117,600.00 | -1.5% | |
| Feb 15, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sale+OE | 7,604 | $15.49 | $117,785.96 | -1.9% | |
| Feb 9, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 13,975 | $15.46 | $216,053.50 | -3.4% |